目的 探讨育龄期月经紊乱的不孕症患者血清性激素水平变化检测结果的临床意义。方法 将120例女性不孕症患者分为月经正常组和月经紊乱组,采用化学发光法测定患者血清LH、FSH、PRL、E2 、T、Pro值,与健康对照组女性血清性激素六项值进行比较分析。结果 月经正常组不孕症患者血清性激素六项水平与健康对照组女性血清性激素六项水平差异无统计学意义,月经紊乱组不孕症患者血清性激素LH[(13.39±5.01) U/L]、FSH[(12.88±3.11) U/L]、PRL[(32.72±4.01) ng/ml]水平明显高于其他两组,差异有统计学意义(P<0.05),E2、T、P水平三组间差异无统计学意义(P>0.05)。结论 分析血清性激素水平变化趋势对育龄期月经功能紊乱女性不孕症患者的临床诊断和治疗有指导意义。
Abstract
Objective To analyze the clinical significance of serum gonadal hormone levels for diagnosis of female infertility due to menstrual irregularity.Methods 120 female infertility patients were divided into two groups: eumenorrhea group and paramenia group. The serum levels of LH,FSH,PRL,E2,Tand PRO of these patients were determined by chemiluminescence Methods and compared with those of healthy women as control.Results There was no statistically significant difference of serum hormone levels between the eumenorrhea group and control. The serum levels of LH[(13.39±5.01) U/L]、FSH[(12.88±3.11) U/L] and PRL[(32.72±4.01) ng/ml] in paramenia group were much higher than those in the other two groups. The difference was of statistical significance (P<0.05),but there was no significant difference of serum levels of E2,T,and PRO between these three groups(P>0.05).Conclusions Analysis of the changes of serum hormone levels can facilitate clinical diagnosis and treatment of female infertility with menstrual irregularity.
关键词
不孕症 /
血清性激素 /
化学发光免疫检测
Key words
infertility /
serum hormone /
chemiluminesent immunoassay
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 吴建伟. 不孕症患者98例血清性激素6项检测分析[J]. 临床和实验医学杂志,2011,10(10): 781-783.
[2] 麦爱芬,梁指荣.96例不孕症患者血清性激素6项检测分析[J].检验医学与临床,2012,9(14):1734-1736.
[3] 胡明江,朱本兴,许玉杰,等.不孕症患者性激素水平的变化[J].标记免疫分析与临床,2001,8(1):18-20.
[4] 李文东,康艳丽,李灿东,等.女性性激素与原发性不孕症相关性的研究[J].现代检验医学杂志,2008,23(4):95-96.
[5] 沈庆茂,方玲,杜国有,等.不孕症患者血清性激素水平的变化[J].检验医学与临床,2007,4(11):1054-1055.
[6] 方琳丽,麦 芒,李俊雄,等.血清性激素测定对女性不孕症的诊断意义[J].实用医技杂志,2004,11(3):338-340.
[7] 高泽芹.女性体内的主要性激素[J].生物学教学,2011,36(1):71-73.
[8] 方琳丽,王鲁华,奚宝珊,等.女性不孕症患者血清性激素水平的变化[J].放射免疫学杂志,2001,13(5):298-299.
[9] 余晓敏.128例不孕症患者血清性激素6项检测分析[J]. 中国医疗前沿,2013,8(24):90-92.
[10] 高小萍. 女性不孕症患者血清性激素水平变化的临床分析[J].中国临床研究,2013,26(7):686-668.
[11] 闻贤平.性激素测定对女性不孕症的诊断价值探讨[J] .放射免疫学杂志,2012,25(4):466-467.
[12] Akira I, Tomoko N. Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review[J].Reproductive Biology and Endocrinology, 2014, 12:125.
[13] Sergio P,Caterina N.serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome[J]. International Journal of General Medicine, 2011,4: 759-763.
[14] 叶 文. 性激素六项水平对不孕症诊断价值分析 [J] .中国性科学, 2015, 9(4): 30-32.
PDF(545 KB)
